chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within a few months of being vaccinated, I started experiencing joint stiffness which steadily worsened in severity and duration for a year before I was diagnosed by two different rheumatologists as having polyarthralgia, and possibly rheumatoid arthritis.  Autoimmune diseases do not run in my family; I was the only one who received these vaccines, and the only one who suffers from this.  It's so bad that holding a toothbrush in the morning is painful and difficult.  I've tried 11 prescription drugs for arthritis so far in the last 5 years. 12/19/07-records received for DOS 1/16/04-1/24/06-seen by rheumatologist-Impression: seroregative rheumatoid arthritis. PE: Low grade synovitis over PIP joints bilaterally, cystic like lesion noted over lateral aspect of right 3rd PIP joint. No tenderness or warmth noted. Symptoms began 1 year ago, . Stiffness in hands. Per 60 day follow up: Residual symptoms arthritis and fibromyalgia. Also rec'd flu shot 11-13-03 (manufacturer was Khiron or Aventis). Lot # W254AA or 254AA. Given at clinic. Follow-up: On my original form, I put my symptom start date as November, but after checking records I have found that the symptoms actually started in early December of 2003. I verified this by checking with my Human Resource department at work - I remembered distinctly that the symptoms started the first week of starting a new position with my company, and started that new position 12/2/03. Also found information on the other vaccine I received. I got a flu shot on 11/13/03 at clinic. The doctor who signed my chart administered the shot at 9:05 in my left arm, intramuscular. They were using two different manufacturers at the time, Khiron and Aventis, and they are not sure which one was used, but it was lot number V1254AA. This vaccine was purchased with my own money, and I did not have any illnesses at the time. Please let me know if you need any more information. I'm not sure what type of medical records would be helpful, but I have office notes and results from bloodwork I've had done in the last 4 years. Also, is there any way for me to find out if there have been other adverse reactions associated with this particular lot number? I'd like to know if I'm the only one who had this sort of reaction, or if there are others with similar or other problems after getting vaccinated with this lot number. 1/13/2010 Rheumatoid Arthritis, Fibromyalgia, and Tinnitus.
Rash got worse/The rash is painful and itchy all over my body at this time; The rash is painful and itchy all over my body at this time; Sores were open and seeping; Sever bruising all over my body; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in left arm at the age of 55-year-old on 27Apr2021 17:00 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was a facility.  Medical history included allergy, blood pressure abnormal, Sulfonamide allergy. Patient was not pregnant. Prior to vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included calcium; ascorbic acid (VIT C); ergocalciferol (VIT D), unspecified medicine for blood pressure abnormal and unspecified medicine for allergy. The patient previously took first dose bnt162b2 for COVID-19 immunisation and 48 hours after the first vaccine patient developed a rash starting on patient's arms, moved to patient's back, then patient's chest and neck. Went to the doctor and received a steroid shot for the itchy rash. The rash got worse by 4/4, returned to the doctor for additional treatment. Patient was given Triamcinolone Acetonide to apply to the rash. Patient was told if patient wanted the 2nd vaccine they could not provide further treatment. Patient received the 2nd vaccine on 27Apr2021 and 48 hours later the rash got worse on 29Apr2021 17:00. Patient had been to ER once because the sores were open and seeping in 2021 and the doctor's office 4 times, receiving 3 steroid shots in total. On 10May2021 patient returned to the doctor with sever bruising all over patient's body in addition to the rash in 2021. The rash is painful and itchy all over patient's body at this time in 2021. sores were open and seeping resulted in [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care]. Other events were resulted in Doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient has not been tested for COVID-19. Therapeutic measures were taken as a result of events (steroid shot, triamcinolone acetonide cream). The outcome of events was not recovered.   Information on the lot/batch number has been requested.
Sore throat, runny nose 10/16 Sore Throat, Runny Nose, Loss of appetite, Lethargy 10/17 8p fever and chills 100 in addition to previous symptoms 10/18 fever and chills 102 no sore throat, other symptoms still present 10/19 fever 99.1 to 100 no sore throat or lethargy other symptoms still present
Shortness of breath / while going for a walk it was hard to catch her breath; no energy like energy is fully drained; blood pressure is off the wall; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath / while going for a walk it was hard to catch her breath), ASTHENIA (no energy like energy is fully drained) and HYPERTENSION (blood pressure is off the wall) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 004H20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), CALCIUM MEFOLINATE, PYRIDOXINE HYDROCHLORIDE, VITAMIN B12 NOS (METANX) and ATORVASTATIN for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath / while going for a walk it was hard to catch her breath), ASTHENIA (no energy like energy is fully drained) and HYPERTENSION (blood pressure is off the wall). The patient was treated with AMLODIPINE at a dose of 5 mg. At the time of the report, DYSPNOEA (Shortness of breath / while going for a walk it was hard to catch her breath), ASTHENIA (no energy like energy is fully drained) and HYPERTENSION (blood pressure is off the wall) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: (Inconclusive) Normal. On an unknown date, Cardiac stress test: (normal) Normal. On an unknown date, Computerised tomogram: (normal) Clear. On an unknown date, Echocardiogram: (normal) Clear. On an unknown date, Pulmonary function test normal: (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Bunch of vitamins includes in the concomitant medication.
excruciating pain occurs when extending arm/trying to reach forward and backward using left arm is excruciating./freezes up shoulder/muscle in arm where injected began to swell; pain in muscle where vaccine was injected; excruciating pain occurs when extending arm/trying to reach forward and backward using left arm is excruciating.; severe pain that extends and freezes up shoulder; excruciating; Swelling reportedly lasted six days; This case was reported by a consumer via call center representative and described the occurrence of injected limb mobility decreased in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th July 2020, the patient received the 1st dose of Shingrix (intramuscular) 50 ug. On 7th July 2020, less than a day after receiving Shingrix, the patient experienced injected limb mobility decreased, muscle pain, pain in arm, shoulder pain, muscle swelling and pain. On an unknown date, the outcome of the injected limb mobility decreased, muscle pain, pain in arm and shoulder pain were not recovered/not resolved and the outcome of the muscle swelling and pain were recovered/resolved.   It was unknown if the reporter considered the injected limb mobility decreased, muscle pain, pain in arm, shoulder pain, muscle swelling and pain to be related to Shingrix.  Additional details were provided as follows: On 7th July 2020, within a matter of hours developed pain in muscle where vaccine was injected. Next, muscle in arm where injected began to swell. Swelling reportedly lasted six days.  Currently, affected arm does not had a constant pain, but excruciating pain occurs when extending arm, and consumer described severe pain that extends and freezes up shoulder. Consumer describes trying to reach forward and backward using left arm is excruciating.  The reporter consent to follow up.
High fever, chills, shorten breathe, dizziness, fatigue, muscle spasms, joint pain
Day of - 1/14/2022 left arm/shoulder pain 0945 1/15/22 dizziness, lightheadedness, passed out, chills, aches, pain in whole body, couldn?t lift head, couldn?t get up
I figured out it was knee bursitis; Limit my activities; irritate when she walk; had to use a walker when forced to move around the house; Tendinitis on left thigh up to left knee; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of GAIT DISTURBANCE (irritate when she walk; had to use a walker when forced to move around the house), TENDONITIS (Tendinitis on left thigh up to left knee), BURSITIS (I figured out it was knee bursitis) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Limit my activities) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TENDONITIS (Tendinitis on left thigh up to left knee). On 18-Apr-2021, the patient experienced GAIT DISTURBANCE (irritate when she walk; had to use a walker when forced to move around the house). On an unknown date, the patient experienced BURSITIS (I figured out it was knee bursitis) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Limit my activities). The patient was treated with CELECOXIB ongoing since an unknown date for Bursitis, at a dose of 200 milligram twice a day; DICLOFENAC SODIUM (topical) ongoing since an unknown date for Bursitis, at a dose of 1 % four times per day and IBUPROFEN for Bursitis, at a dose of 1 dosage form. At the time of the report, GAIT DISTURBANCE (irritate when she walk; had to use a walker when forced to move around the house) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Limit my activities) had not resolved, TENDONITIS (Tendinitis on left thigh up to left knee) was resolving and BURSITIS (I figured out it was knee bursitis) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  On 26MAY2021, the patient went to her primary care doctor who confirmed the diagnosis of bursitis.  Concomitant product use was not provided. Treatment also included ice packs.   This case was linked to MOD-2021-117892 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Completed ADR Form: Updated reporter's address, patient demographics, second dose details, added treatment medications and one additional event "Bursitis" and the outcome of the event tendonitis change from unknown to recovering.
She developed blood clots in her lungs, legs and all over her body; She developed blood clots in her lungs; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 75-year-old female patient received bnt162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "she is allergic to a lot of things" (unspecified if ongoing), notes: She is allergic to a lot of things. The patient's concomitant medications were not reported. The following information was reported: THROMBOSIS (medically significant), outcome "unknown", described as "She developed blood clots in her lungs, legs and all over her body"; PULMONARY THROMBOSIS (medically significant), outcome "unknown", described as "She developed blood clots in her lungs".  Clinical course: Reporter States she wants to know the ingredients as after she took the pfizer covid vaccine, she developed blood clots in her lungs, legs and all over her body. States she almost died. States she has respiratory problems (unclear of timing) and needs to take the 'lung vaccine."  States she is allergic to a lot of things. She is not sure that she wants to take the Pfizer RSV vaccine as states pfizer has ingredients in their vaccine (covid) that 'is not good for her."   Upon further clarification, caller states she had 2 Pfizer covid shots and one pfizer booster for covid and after every shot, she developed blood clots. Also states last year, she had a flu vaccine that was 'mixed' together with a pfizer covid vaccine and developed blood clots as well. Attempted to clarify further however caller unable to clarify. states she is 75 years of age.    The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300311939 same reporter, patient,event, different dose;US-PFIZER INC-202300312117 same reporter, patient,event, different dose;
Information has been received from a registered nurse concerning a 10 year old white male who on 27-OCT-1997 was vaccinated IM (also reported as SC) with a 0.5 mL first dose of Varivax (lot # 623652/0805E). There were no other concomitant vaccines. On 03-OCT-2006, the patient began to feel nauseous. Then on 04-OCT-2006, the patient developed a chickenpox-like rash. As of 06-OCT-2006, the patient's rash was still spreading and there were greater than 100 lesions. The patient has not had a fever. No diagnostic laboratory tests were performed. Unspecified medical attention was sought. A product quality complaint was not involved. Follow-up information was received from a registered nurse who reported that on 06-OCT-2006, a phone call was received from the patient's mother who reported that on 04-OCT-2006 the patient had approximately 100 spots all over the body. The mother reported that there was an outbreak in the area and she was to call her physician. No further information was provided.
4 months after my Booster shot, on 1/11/2022 I noticed a large abscess formed above my elbow on my right arm and a second on my lower back above the waist, palpating it when noticing it when it was marble shaped. It continued to grow and became painful to the touch and I could feel it when I wasn't touching it as well. On Feb. 15th one on my back opened up and had to be drained. Feb. 25th the right arm abscess and back abscess had an IND performed. They are still in the process of healing and have not completely healed since. I was not given any prescriptions as well.
WHEN SHOT WAS BEING ADMINISTERED I FELT IT TRICKLING DOWN MY ARM. WHEN I LET THE NURSE KNOW AND SHE LOOKED AT IT AND PULLED IT OUT NEEDLE CAME OFF THE SYRINGE AND FELL TO THE FLOOR. I AM NOT SURE IF ANY OF THE VACCINE GOT ADMINISTERED. THIS HAS CAUSED ME TO LOSE MY PEACE OF MIND. THEY SAID THEY CANNOT GIVE ME ANOTHER DOSE BECAUSE THERE WAS NO WAY TO TELL HOW MUCH ACTUALLY WENT IN AND AN OVERDOSE CAN BE HARMFUL. I WAS TOLD TO JUST COME FOR MY SECOND DOSE AS SCHEDULED AND I WOULD BE ALRIGHT. I NEED SOMEONE MORE KNOWLEDGABLE TO ASSURE ME OF THIS.
sore arm; fatigue; This is a spontaneous report from a contactable consumer. This consumer (patient's wife) reported for a male patient of an unknown age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose via an unknown route on an unknown date for Covid-19 immunization. Medical history and concomitant drug were not provided. Patient had nothing but a sore arm and some fatigue. Outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Feeling tired; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 76 year-old female patient patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 20Feb2021 11:15 (Lot number: EL9266) at the age of 76 years as dose 1, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 20Feb2021, outcome "unknown", described as "Feeling tired".  Additional information: The patient had not received any other vaccine within 4 weeks.  No follow-up attempts are possible. No further information is expected.
Rash to right upper arm at an around injection site. Pt C/O itching that started the morning of 2/28/18. Pt was given prednisolone 15mg/5ml BID for 4 days.
Severe tendon pain and mild swelling that went down his left arm. Felt like tennis elbow.
Received 2nd dose of covid19 vaccine on Wednesday 3-24-2021, felt fine Thursday, Friday loss of appetite tired, Saturday lethargic could barely function on his own. Sunday morning lethargic, weak, could not walk very well, complained of shortness of breath.  Called 911 and took to emergency room. White blood count off, platelet level low, 14,000
Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 immunisation.     Previously administered products included for an unreported indication: PNEUMOCOCCAL VACCINE on 15-Mar-2021.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Patient received pneumonia vaccine between 1st and 2nd dose.  No treatment information was reported.
Pt felt like he was going to pass out while getting the vaccine shot. Said he has a hx of syncopal episodes when receiving shots. He was placed in ambulance and felt better after a few minutes.
achy; tired; Felt like flu, achy and tired; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like flu, achy and tired), PAIN (achy) and FATIGUE (tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Flu: flu shot on 12-Jan-2021.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 12-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like flu, achy and tired). On 23-Jan-2021, the patient experienced PAIN (achy) and FATIGUE (tired).   On 24-Jan-2021, PAIN (achy) and FATIGUE (tired) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Felt like flu, achy and tired) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.   This case was linked to MOD-2021-006595 (Patient Link).
dizzy; throwing up; Head spinning; nausea; This is a spontaneous report from a contactable nurse (patient).  A 22-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL1284), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation.  There were no medical history or concomitant medications.  The patient started to get like extremely dizzy, was throwing up, head spinning, had horrible nausea; started to get really carsick on an unspecified date. The patient went into a walk in a clinic and that gave her ondansetron (ZOFRAN). So, she had been taking that for the nausea and the vomiting. She had also been taking meclozine (MECLIZINE) and dimenhydrinate (DRAMAMINE) too. The outcome of event dizzy was not recovered, while for other events was unknown.
Localized rash, headache, night sweats pain in arm significantly more severe than after previous flu shots. Symptoms started around 6 to 7 pm and resolved overnight
Shortly after the 2nd shot of Moderna my tongue/taste buds felt ?prickly? and I had a metallic taste in my mouth. The metallic taste went away by the evening but not the tongue sensation. By the evening of the first day I had patches of irritation develop along the edges of my tongue. I didn?t really pay too much attention to it until I ate some hot sauce the next day! I took pictures 2 days after the shot. My symptoms are closest to what has been described as ?Covid tongue?. My tongue symptoms have varied  day to day but haven?t  cleared yet (a month later).
shock-collapse; hypotonic, hyporesponsive collapse; turning of eyes to th lt; bradycardia; heart rate inc to 110; pt recovered in about 5 mins by lowering upper part of body;
we vaccinated patient with expired medication; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (we vaccinated patient with expired medication) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 067H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (we vaccinated patient with expired medication). At the time of the report, EXPIRED PRODUCT ADMINISTERED (we vaccinated patient with expired medication) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-600773, US-MODERNATX, INC.-MOD-2022-600743, US-MODERNATX, INC.-MOD-2022-600769, US-MODERNATX, INC.-MOD-2022-600775 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2022: Follow up received included patient details added hence report type changed to spontaneous from invalid case.; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-600773:Same reporter US-MODERNATX, INC.-MOD-2022-600769:Same reporter US-MODERNATX, INC.-MOD-2022-600743:Same reporter US-MODERNATX, INC.-MOD-2022-600775:Same reporter